TLR7 agonism accelerates disease in a mouse model of primary Sjögren's syndrome and drives expansion of T-bet<sup>+</sup> B cells.

Front Immunol · 2022 · PMC9799719 · PMID 36591307

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

did not reach statistical significancep = 0.053so close (0.05 < p ≤ 0.1)

While BAFF levels tended to be higher in the BL/10 Imq-treated mice as compared to sham-treated controls, this difference did not reach statistical significance (p = 0.053) ( Supplementary Figure 4E ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.